Go to:
Logótipo
You are here: Start > Publications > View > 3,4-Methylenedioxypyrovalerone (MDPV): in vitro mechanisms of hepatotoxicity under normothermic and hyperthermic conditions
Today is sunday
Concurso de Escrita Criativa da FEUP
Publication

3,4-Methylenedioxypyrovalerone (MDPV): in vitro mechanisms of hepatotoxicity under normothermic and hyperthermic conditions

Title
3,4-Methylenedioxypyrovalerone (MDPV): in vitro mechanisms of hepatotoxicity under normothermic and hyperthermic conditions
Type
Article in International Scientific Journal
Year
2016
Authors
Valente, MJ
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Araujo, AM
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Silva, R
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Maria de Lourdes Bastos
(Author)
FFUP
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page View ORCID page
Felix Carvalho
(Author)
FFUP
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page Without ORCID
Carvalho, M
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Journal
Vol. 90
Pages: 1959-1973
ISSN: 0340-5761
Publisher: Springer Nature
Other information
Authenticus ID: P-00K-110
Abstract (EN): Synthetic cathinones have emerged in recreational drug markets as legal alternatives for classical amphetamines. Though currently banned in several countries, 3,4-methylenedioxypyrovalerone (MDPV) is one of the most commonly abused cathinone derivatives worldwide. We have recently reported the potential of MDPV to induce hepatocellular damage, but the underlying mechanisms responsible for such toxicity remain to be elucidated. Similar to amphetamines, a prominent toxic effect of acute intoxications by MDPV is hyperthermia. Therefore, the present in vitro study aimed to provide insights into cellular mechanisms involved in MDPV-induced hepatotoxicity and also evaluate the contribution of hyperthermia to the observed toxic effects. Primary cultures of rat hepatocytes were exposed to 0.2-1.6 mM MDPV for 48 h, at 37 or 40.5 A degrees C, simulating the rise in body temperature that follows MDPV intake. Cell viability was measured through the MTT reduction and LDH leakage assays. Oxidative stress endpoints and cell death pathways were evaluated, namely the production of reactive oxygen and nitrogen species (ROS and RNS), intracellular levels of reduced (GSH) and oxidized (GSSG) glutathione, adenosine triphosphate (ATP) and free calcium (Ca2+), as well as the activities of caspases 3, 8 and 9, and nuclear morphological changes with Hoechst 33342/PI double staining. At 37 A degrees C, MDPV induced a concentration-dependent loss of cell viability that was accompanied by GSH depletion, as one of the first signs of toxicity, observed already at low concentrations of MDPV, with negligible changes on GSSG levels, followed by accumulation of ROS and RNS, depletion of ATP contents and increases in intracellular Ca2+ concentrations. Additionally, activation of caspases 3, 8, and 9 and apoptotic nuclear morphological changes were found in primary rat hepatocytes exposed to MDPV, indicating that this cathinone derivative activates both intrinsic and extrinsic apoptotic death pathways. The cytotoxic potential of MDPV and all the studied endpoints were markedly aggravated under hyperthermic conditions (40.5 A degrees C). In conclusion, these data suggest that MDPV toxicity in primary rat hepatocytes is mediated by oxidative stress, subsequent to GSH depletion and increased ROS and RNS accumulation, mitochondrial dysfunction, and impairment of Ca2+ homeostasis. Furthermore, the rise in body temperature subsequent to MDPV abuse greatly exacerbates its hepatotoxic potential.
Language: English
Type (Professor's evaluation): Scientific
No. of pages: 15
Documents
We could not find any documents associated to the publication.
Related Publications

Of the same authors

Hepatic oxidative stress induced by methylone and MDPV: A comparison to MDMA (2015)
Other Publications
Valente, MJ; Araujo, AM; Silva, R; Maria de Lourdes Bastos; Felix Carvalho; Guedes de Pinho, PG; Carvalho, M

Of the same journal

Update on 1-benzylpiperazine (BZP) party pills (2013)
Another Publication in an International Scientific Journal
Marcia Sa Monteiro; Maria de Lourdes Bastos; de Pinho, PG; Marcia Carvalho
Toxicity of amphetamines: an update (2012)
Another Publication in an International Scientific Journal
Marcia Carvalho; Helena Carmo; Vera Marisa Costa; Joao Paulo Capela; Helena Pontes; Fernando Remiao; Felix Carvalho; Maria de Lourdes Bastos
The hallucinogenic world of tryptamines: an updated review (2015)
Another Publication in an International Scientific Journal
Ana Margarida Araujo; Felix Carvalho; Maria de Lourdes Bastos; Guedes de Pinho, P; Marcia Carvalho
The hallucinogenic world of tryptamines: an updated review (2015)
Another Publication in an International Scientific Journal
Araujo, AM; Carvalho, F; Bastos, ML; Guedes de Pinho, P; Carvalho, M
Reply to the commentary by Sarode and Sarode on "Genetic toxicology and toxicokinetics of arecoline and related areca nut compounds: an updated review" (2021)
Another Publication in an International Scientific Journal
Oliveira, NG; Ramos, DL; Ricardo Jorge Dinis Oliveira

See all (67)

Recommend this page Top
Copyright 1996-2024 © Faculdade de Engenharia da Universidade do Porto  I Terms and Conditions  I Accessibility  I Index A-Z  I Guest Book
Page generated on: 2024-07-21 at 19:15:06 | Acceptable Use Policy | Data Protection Policy | Complaint Portal